Cellebrite DI downgraded by BofA Securities with a new price target
$CLBT
Computer Software: Prepackaged Software
Technology
BofA Securities downgraded Cellebrite DI from Buy to Neutral and set a new price target of $6.00 from $6.50 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/28/2024 | $13.00 → $13.50 | Buy | Needham |
| 3/13/2024 | Mkt Perform → Outperform | William Blair | |
| 2/16/2024 | $9.00 → $12.00 | Neutral → Buy | BofA Securities |
| 7/19/2023 | $11.00 | Buy | Craig Hallum |
| 8/12/2022 | $6.50 → $6.00 | Buy → Neutral | BofA Securities |
| 8/12/2022 | Outperform → Mkt Perform | William Blair | |
| 2/24/2022 | $10.50 | Overweight | JP Morgan |
| 2/11/2022 | $10.50 | Buy | Deutsche Bank |
144 - Cellebrite DI Ltd. (0001854587) (Subject)
6-K - Cellebrite DI Ltd. (0001854587) (Filer)
144 - Cellebrite DI Ltd. (0001854587) (Subject)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID: CLBTQ424Event URL:https://investor
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming Needham & Company Growth Conference. Relevant details include: Date:January 14, 2025Conference:Needham & Company 27th Annual Growth ConferencePresentation Time:8:45 a.m. ETFormatFireside ChatEvent URL:https://investors.cellebrite.com/events/event-details/needham-co-27th-annual-growth-conferenceCellebrite Executives:Dana Gerner, chief financial officerAndrew Kramer, vice president, investor relations About Cellebrite Cellebrite's (
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to
Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously
William Blair upgraded Cellebrite DI from Mkt Perform to Outperform
BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)
SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID: CLBTQ424Event URL:https://investor
Third-quarter 2024 revenue of $106.9 million exceeds $100 million quarterly revenue milestone for the first time in Company history Third-quarter 2024 revenue increased 27% year-over-year primarily due to 27% growth in subscription revenue ARR of $370.8 million, up 26% year-over-year Third-quarter 2024 adjusted EBITDA of $31.3 million, 29.3% adjusted EBITDA margin Company increases 2024 outlook for revenue and adjusted EBITDA, and raises the low end of the 2024 ARR target range TYSONS CORNER, VA and PETAH TIKVA, ISRAEL, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announ
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its third-quarter 2024 financial results before market open on Wednesday, November 6, 2024. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the third quarter of 2024 and discuss its 2024 outlook. Relevant details include: Date:Wednesday, November 6, 2024Time:8:30 a.m. ETCall-In Number:203-518-9766Conference ID: CLBTQ324Event URL:https://investors.cellebrite.com/events/event-det
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022